Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-19-055941

Chief Executive Officer bought 1,430 shares at $4.26 ($6,092)

From the SEC's structured data for this filing

Trades in this filing

Cohen Yuval · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-12 Purchase : show line 1 in the form +1,430 $4.26 $6,092 66,790 D
Open-market purchases · 1,430 sh · avg $4.26 · $6,092
Loading xslF345X03/doc4.xml…